ArticlePloS one2026

Retraction: Efficacy and safety of aripiprazole or bupropion augmentation and switching in patients with treatment-resistant depression or major depressive disorder: A systematic review and meta-analysis of randomized controlled trials.

PLOS One EditorsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.